A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...
Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...
As President Trump touts his own executive orders to lower drug prices, the Medicare drug price negotiations begun during the Biden administration are continuing behind the scenes. Two companies – ...
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did not receive support from any Republican senators. In 2025, ...
Recently approved delays and exemptions to the CMS drug price negotiation program are projected to cost $8.8 billion over 10 years, according to a Congressional Budget Office report published Oct. 20.
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — President Trump ...
“There is no protected property interest in selling goods to Medicare beneficiaries…at a price higher than what the government is willing to pay when it reimburses those costs.” – District Court for ...
A provision protecting expensive medications, used to treat multiple rare diseases, from the Medicare drug price negotiations made its way back into the GOP budget reconciliation bill after a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback